• Explore /
  • Poster
  • / Immune marker profiling and PD-L1, PD-L2 expression mechanisms across non-small cell lung cancer mutations.

Immune marker profiling and PD-L1, PD-L2 expression mechanisms across non-small cell lung cancer mutations.

Abstract Poster

Authors

null

Maria Toki

Yale School of Medicine, New Haven, CT

Maria Toki , Nikita Mani , James William Smithy , Yuting Liu , Mehmet Altan , Brad Wasserman , Rasikh Tuktamyshov , Konstantinos N. Syrigos , David L. Rimm

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 35, 2017 (suppl; abstr 9076)

DOI

10.1200/JCO.2017.35.15_suppl.9076

Abstract #

9076

Poster Bd #

402

Abstract Disclosures

Similar Posters

First Author: Masayuki Shirasawa

First Author: Antonio Calles

Poster

2014 ASCO Annual Meeting

PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).

PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).

First Author: Sascha Ansen

First Author: Wei Wu